Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
| ▸ | TLR2 | O60603 | 2/20 | 0.44 |
| ▸ | MDM4 | O15151 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | MDM2 | Q00987 | 4/20 | 0.44 |
| ▸ | CASP3 | P42574 | 2/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21785029 | 0.97 | HDAC1 (0.46) | HDAC1HDAC2MDM4TP53MDM2 | |
| SCHEMBL12221123 | 0.91 | TLR2 (0.53) | HDAC1HDAC2TLR2MDM4TP53 | |
| SCHEMBL12221104 | 0.91 | TLR2 (0.53) | HDAC1HDAC2TLR2MDM4TP53 | |
| SCHEMBL17633370 | 0.91 | MDM2 (0.51) | HDAC1HDAC2TLR2MDM4TP53 | |
| SCHEMBL31004028 | 0.91 | TLR2 (0.53) | HDAC1HDAC2TLR2MDM4TP53 | |
| SCHEMBL29398713 | 0.91 | TLR2 (0.53) | HDAC1HDAC2TLR2MDM4TP53 | |
| Hydrochloric Acid SCHEMBL25358748 | 0.90 | TLR2 (0.54) | HDAC1HDAC2TLR2MDM4TP53 | |
| Hydrochloric Acid SCHEMBL30003033 | 0.90 | TLR2 (0.54) | HDAC1HDAC2TLR2MDM4TP53 | |
| Hydrochloric Acid SCHEMBL29217894 | 0.90 | TLR2 (0.54) | HDAC1HDAC2TLR2MDM4TP53 | |
| Hydrochloric Acid SCHEMBL25358745 | 0.90 | TLR2 (0.54) | HDAC1HDAC2TLR2MDM4TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2023-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | DNPEP, BCAT1, ANPEP | HDAC1 4555/4885HDAC2 4644/4885TLR2 3866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.